Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 1;7(1):13.
doi: 10.1186/s40842-021-00127-6.

Recurrent DKA results in high societal costs - a retrospective study identifying social predictors of recurrence for potential future intervention

Affiliations

Recurrent DKA results in high societal costs - a retrospective study identifying social predictors of recurrence for potential future intervention

Ryan Lyerla et al. Clin Diabetes Endocrinol. .

Abstract

Aims: Diabetic ketoacidosis (DKA) is an emergency with high morbidity and mortality. This study examined patient factors associated with hospitalization for recurrent DKA.

Methods: Characteristics of 265 subjects admitted for DKA at Hennepin County Medical Center between January 2017 and January 2019 were retrospectively analyzed. Differences between subjects with a single admission versus multiple were reviewed.

Results: Forty-eight out of 265 patients had recurrent DKA. Risk factors included African American race (adjusted odds ratio (aOR) versus white non-Hispanic = 4.6, 95% CI 1.8-13, p = 0.001) or other race/ethnicity (aOR = 8.6, 2.9-28, p < 0.0001), younger age (aOR 37-52y versus 18-36y = 0.48, 0.19-1.16, p = 0.10; aOR 53-99y versus 18-36y = 0.37, 0.12-0.99, p = 0.05), type 1 diabetes mellitus (aOR = 2.4, 1.1-5.5, p = 0.04), ever homeless (aOR = 2.5, 1.1-5.4, p = 0.03), and drug abuse (aOR = 3.2, 1.3-7.8, p = 0.009). DKA cost a median of $29,981 per admission.

Conclusions: Recurrent DKA is costly, and social determinants are strong predictors of recurrence. This study highlights the need for targeted preventative care programs.

Keywords: Barriers to care; Insulin cost; Recurrent DKA.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycemia. Nat Rev Endocrinol. 2016;12:222–232. doi: 10.1038/nrendo.2016.15. - DOI - PubMed
    1. Benoit S, Zhang Y, Geiss L, et al. Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality - United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2018;67(12):362–365. doi: 10.15585/mmwr.mm6712a3. - DOI - PMC - PubMed
    1. Lebovitz HE. Diabetic ketoacidosis. Lancet (London, England) 1995;345(8952):767–772. doi: 10.1016/s0140-6736(95)90645-2. - DOI - PubMed
    1. Morris A, Boyle D, McMahon A. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin dependent diabetes mellitus. Lancet. 1997;305:1505–1510. doi: 10.1016/S0140-6736(97)06234-X. - DOI - PubMed
    1. Wright J, Ruck K, Rabbitts R, Charlton M, et al. Diabetic ketoacidosis (DKA) in Birmingham, UK 2000–2009: an evaluation of risk factors for recurrence and mortality. Br J DIabetes Vasc Dis. 2009;9:278–282. doi: 10.1177/1474651409353248. - DOI

LinkOut - more resources